成人2型糖尿病每日多次胰岛素注射患者接受结构化教育的持续葡萄糖监测:多中心随机对照试验
这项24周多中心随机对照试验纳入159例每日多次胰岛素注射的2型糖尿病成人患者,随机分为间歇扫描式持续葡萄糖监测(isCGM)联合结构化教育组、isCGM联合常规教育组和血糖监测(BGM)联合常规教育组,主要终点为24周HbA1c变化。结果显示结构化教育组HbA1c降幅大于两个对照组,不良事件发生率在BGM组较高。
要点
- isCGM联合结构化教育组24周HbA1c较基线下降10.96 mmol/mol,大于两个对照组。
- isCGM联合常规教育组HbA1c变化与BGM联合常规教育组接近。
- 不良事件发生率在BGM联合常规教育组为48.08%,高于两个isCGM组。
核心结论
- 在每日多次胰岛素注射的2型糖尿病成人中,提供CGM图形模式解读的结构化教育时,单独使用isCGM可使HbA1c降幅更大。
研究设计与样本
- 24周随机开放标签多中心试验,纳入HbA1c 58-108 mmol/mol(7.5-12.0%)的成人2型糖尿病每日多次胰岛素注射患者。
- 按1:1:1随机分为isCGM联合结构化教育组(干预组)、isCGM联合常规教育组(对照1组)和BGM联合常规教育组(对照2组),区组随机化由独立统计师执行。
- 共159例随机(每组53例),全分析集148例:干预组52例、对照1组49例、对照2组47例。
主要发现
- 基线平均HbA1c为68.19±10.94 mmol/mol(8.39±1.00%)。
- 24周HbA1c较基线最小二乘均值变化:干预组-10.96±1.35 mmol/mol(-1.00±0.12%),对照1组-6.87±1.39 mmol/mol(-0.63±0.13%),与干预组比较p=0.0367。
- 24周HbA1c较基线最小二乘均值变化:对照2组-6.32±1.42 mmol/mol(-0.58±0.13%),与干预组比较p=0.0193。
- 不良事件发生率:干预组28.85%(15/52),对照1组26.42%(14/53),对照2组48.08%(25/52)。
局限性
- 由于干预性质,无法对参与者和研究者设盲。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The aim of this study was to compare the effectiveness of stand-alone intermittently scanned continuous glucose monitoring (isCGM) with or without a structured education programme and blood glucose monitoring (BGM) in adults with type 2 diabetes on multiple daily insulin injections (MDI). METHODS: In this 24 week randomised open-label multicentre trial, adults with type 2 diabetes on intensive insulin therapy with HbA1c levels of 58-108 mmol/mol (7.5-12.0%) were randomly assigned in a 1:1:1 ratio to isCGM with a structured education programme on adjusting insulin dose and timing according to graphical patterns in CGM (intervention group), isCGM with conventional education (control group 1) or BGM with conventional education (control group 2). Block randomisation was conducted by an independent statistician. Due to the nature of the intervention, blinding of participants and investigators was not possible. The primary outcome was change in HbA1c from baseline at 24 weeks, assessed using ANCOVA with the baseline value as a covariate. RESULTS: A total of 159 individuals were randomised (n=53 for each group); 148 were included in the full analysis set, with 52 in the intervention group, 49 in control group 1 and 47 in control group 2. The mean (± SD) HbA1c level at baseline was 68.19±10.94 mmol/mol (8.39±1.00%). The least squares mean change (± SEM) from baseline HbA1c at 24 weeks was -10.96±1.35 mmol/mol (-1.00±0.12%) in the intervention group, -6.87±1.39 mmol/mol (-0.63±0.13%) in control group 1 (p=0.0367 vs intervention group) and -6.32±1.42 mmol/mol (-0.58±0.13%) in control group 2 (p=0.0193 vs intervention group). Adverse events occurred in 28.85% (15/52) of individuals in the intervention group, 26.42% (14/53) in control group 1 and 48.08% (25/52) in control group 2. CONCLUSIONS/INTERPRETATION: Stand-alone isCGM offers a greater reduction in HbA1c in adults with type 2 diabetes on MDI when education on the interpretation of graphical patterns in CGM is provided. TRIAL REGISTRATION: ClinicalTrials.gov NCT04926623. FUNDING: This study was supported by Daewoong Pharmaceutical Co., Ltd.
引用
- Kim JY, Jin SM, Sim KH, et al. Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial. Diabetologia. 2024. PMID: 38639876. doi:10.1007/s00125-024-06152-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。